title: A116C angiotensin II type 1 receptor gene polymorphism may predict hemodynamic response to losartan in patients with cirrhosis and portal hypertension.
authors.forename: Wilko
authors.initials: W
authors.lastname: Spiering
authors.forename: Abraham A
authors.initials: AA
authors.lastname: Kroon
authors.forename: Peter W
authors.initials: PW
authors.lastname: de Leeuw
mesh_terms: D000225:Adenine; D000483:Alleles; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use; D003596:Cytosine; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D006975:Hypertension, Portal / Q000503:physiopathology*; D007093:Imidazoles / Q000627:therapeutic use; D008103:Liver Cirrhosis / Q000188:drug therapy* / Q000503:physiopathology; D019808:Losartan / Q000627:therapeutic use*; D011110:Polymorphism, Genetic / Q000235:genetics*; D044140:Receptor, Angiotensin, Type 1 / Q000235:genetics*; D013777:Tetrazoles / Q000627:therapeutic use
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents; D007093:Imidazoles; D044140:Receptor, Angiotensin, Type 1; D013777:Tetrazoles; D003596:Cytosine; C066026:losartan carboxylic acid; D000225:Adenine; D019808:Losartan